Literature DB >> 17145119

Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.

Jianhua S Yao1, Fanxia Shen, William L Young, Guo-Yuan Yang.   

Abstract

Smooth muscle cell migration plays an important role during angiogenesis and vascular remodeling. In this study, we examined the effects of doxycycline and minocycline on vascular endothelial growth factor (VEGF)-induced human aortic smooth muscle cell (HASMCs) migration, and explored the mechanisms in which doxycycline or minocycline inhibit HASMC migration. We demonstrated that both doxycycline and minocycline attain consistent anti-angiogenic effects in the inhibition of HASMC migration via a different signal pathway (p<0.05). This effect is through attenuating VEGF-induced matrix metalloproteinase-9 (MMP-9) activity (p<0.05). Doxycycline could increase tissue inhibitors of metalloproteinases-1 (TIMP-1) expression while minocycline down-regulated PI3K/Akt phosphorylation in HASMC. Our study suggests that doxycycline has a stronger ability to inhibit MMP secretion in HASMC by up-regulating endogenous MMPs inhibitor TIMP-1, while minocycline implements anti-angiogenic effect through inhibiting HASMC migration by down-regulating PI3K/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145119      PMCID: PMC1876824          DOI: 10.1016/j.neuint.2006.10.008

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  53 in total

1.  Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1.

Authors:  S D Shapiro; D K Kobayashi; H G Welgus
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

2.  Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells.

Authors:  Y A De Clerck; T D Yean; B J Ratzkin; H S Lu; K E Langley
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

3.  Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO.

Authors:  F Tronc; Z Mallat; S Lehoux; M Wassef; B Esposito; A Tedgui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

4.  Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases.

Authors:  C Knall; G S Worthen; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases.

Authors:  Jianhua S Yao; Yongmei Chen; Wenwu Zhai; Kaiyan Xu; William L Young; Guo-Yuan Yang
Journal:  Circ Res       Date:  2004-07-15       Impact factor: 17.367

Review 6.  Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.

Authors:  L M Golub; N S Ramamurthy; T F McNamara; R A Greenwald; B R Rifkin
Journal:  Crit Rev Oral Biol Med       Date:  1991

7.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; Y Gonoji; K Naka; K Tomita; I Nakanishi; K Iwata; K Yamashita; T Hayakawa
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

8.  Human 92- and 72-kilodalton type IV collagenases are elastases.

Authors:  R M Senior; G L Griffin; C J Fliszar; S D Shapiro; G I Goldberg; H G Welgus
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

9.  Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid.

Authors:  H G Welgus; G P Stricklin
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model.

Authors:  Chanhung Z Lee; Bin Xu; Tomoki Hashimoto; Charles E McCulloch; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

View more
  23 in total

1.  Effects of doxycycline on intestinal ischemia reperfusion injury induced by abdominal compartment syndrome in a rat model.

Authors:  N Fatih Yaşar; Riza Ozdemir; Enver Ihtiyar; Nilüfer Erkasap; Tülay Köken; Murat Tosun; Setenay Oner; Serdar Erkasap
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

2.  Comparative Evaluation of the Cytotoxic and Angiogenic Effects of Minocycline and Clindamycin: An In Vitro Study.

Authors:  Nileshkumar Dubey; Jinping Xu; Zhaocheng Zhang; Jacques E Nör; Marco C Bottino
Journal:  J Endod       Date:  2019-05-24       Impact factor: 4.171

3.  Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.

Authors:  P R Nagareddy; P S Rajput; H Vasudevan; B McClure; U Kumar; K M Macleod; J H McNeill
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.

Authors:  Chenju Yi; Zhiyuan Zhang; Wei Wang; Caroline Zug; Hermann J Schluesener; Zhiren Zhang
Journal:  Neurochem Res       Date:  2011-06-08       Impact factor: 3.996

5.  Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy.

Authors:  Sachiko Homma; Mary Lou Beermann; Jeffrey Boone Miller
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

6.  Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

Authors:  Livia S Machado; Irina Y Sazonova; Anna Kozak; Daniel C Wiley; Azza B El-Remessy; Adviye Ergul; David C Hess; Jennifer L Waller; Susan C Fagan
Journal:  Stroke       Date:  2009-07-23       Impact factor: 7.914

7.  Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Mary Lou Beermann; Vivek K Vishnudas; Sachiko Homma; Jeffrey Boone Miller
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

Review 8.  Effect of biomaterials on angiogenesis during vital pulp therapy.

Authors:  Mohammad Ali Saghiri; Armen Asatourian; Franklin Garcia-Godoy; Nader Sheibani
Journal:  Dent Mater J       Date:  2016-08-20       Impact factor: 2.102

9.  Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

Authors:  Yuri Cho; Hyo Jin Son; Eun-Mee Kim; Ji Hyun Choi; Sung Tae Kim; In Jung Ji; Dong Hee Choi; Tong H Joh; Yoon Seong Kim; Onyou Hwang
Journal:  Neurotox Res       Date:  2009-07-07       Impact factor: 3.911

10.  Takayasu's arteritis.

Authors:  Curry L Koening; Carol A Langford
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.